Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.260
-0.140 (-3.18%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Coya Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Net Income
-21.23-14.88-7.99-12.24-4.89
Upgrade
Depreciation & Amortization
0.030.030.030.030.02
Upgrade
Other Amortization
---1-
Upgrade
Asset Writedown & Restructuring Costs
2.290.030.540.53-
Upgrade
Stock-Based Compensation
4.292.660.870.210.23
Upgrade
Other Operating Activities
---2.5-
Upgrade
Change in Accounts Payable
-0.530.480.30.850.67
Upgrade
Change in Unearned Revenue
0.450.31.5--
Upgrade
Change in Other Net Operating Assets
3.951.1-6.44-0.090.07
Upgrade
Operating Cash Flow
-10.74-10.29-11.19-7.24-3.9
Upgrade
Capital Expenditures
-----0.14
Upgrade
Sale (Purchase) of Intangibles
-1.16-0.03-0.54-0.53-
Upgrade
Investing Cash Flow
-1.16-0.03-0.54-0.53-0.14
Upgrade
Long-Term Debt Issued
---10.47-
Upgrade
Total Debt Issued
---10.47-
Upgrade
Net Debt Issued (Repaid)
---10.47-
Upgrade
Issuance of Common Stock
20.3916.1638.4300
Upgrade
Other Financing Activities
--0.13--1.11-0.34
Upgrade
Financing Cash Flow
20.3916.0338.439.36-0.34
Upgrade
Net Cash Flow
8.485.7126.691.59-4.38
Upgrade
Free Cash Flow
-10.74-10.29-11.19-7.24-4.04
Upgrade
Free Cash Flow Margin
-135.16%-289.50%-186.41%--
Upgrade
Free Cash Flow Per Share
-0.64-0.68-1.10-2.79-1.56
Upgrade
Levered Free Cash Flow
-4.61-6.73-10.33-3.43-2.45
Upgrade
Unlevered Free Cash Flow
-4.61-6.73-10.33-4.43-2.45
Upgrade
Change in Working Capital
3.881.88-4.640.750.74
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.